MESO logo

Mesoblast Limited (MESO) Company Overview

Profile

Full Name:

Mesoblast Limited

Sector:

Healthcare

Industry:

Biotechnology

Country:

Australia

IPO:

January 20, 2010

Indexes:

Not included

Description:

Mesoblast Limited is a biotechnology company focused on developing innovative cell-based therapies. It specializes in using mesenchymal stem cells to treat various conditions, including chronic pain, heart disease, and inflammatory disorders, aiming to improve patient outcomes through advanced regenerative medicine.

Key Details

Price

$16.36

Annual Revenue

$5.90 M(-21.32% YoY)

Annual EPS

-$89.10(+15.38% YoY)

Annual ROE

-17.91%

Beta

1.03

Events Calendar

Earnings

Next earnings date:

Feb 28, 2025

Recent quarterly earnings:

Aug 28, 2024

Recent annual earnings:

Aug 28, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Jan 10, 2024

Analyst ratings

Recent major analysts updates

Feb 7, 25 Piper Sandler
Overweight
Dec 23, 24 Jefferies
Hold
Dec 19, 24 Piper Sandler
Overweight
Jul 23, 24 Piper Sandler
Overweight
Jun 20, 24 Cantor Fitzgerald
Overweight
Jun 4, 24 Cantor Fitzgerald
Overweight
Sep 21, 23 Cantor Fitzgerald
Overweight
Aug 31, 23 Jefferies
Buy
Aug 31, 23 Cantor Fitzgerald
Overweight
Aug 7, 23 Maxim Group
Hold

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Mesoblast Limited?
  • Does Mesoblast Limited pay dividends?
  • What sector is Mesoblast Limited in?
  • What industry is Mesoblast Limited in?
  • What country is Mesoblast Limited based in?
  • When did Mesoblast Limited go public?
  • Is Mesoblast Limited in the S&P 500?
  • Is Mesoblast Limited in the NASDAQ 100?
  • Is Mesoblast Limited in the Dow Jones?
  • When was Mesoblast Limited's last earnings report?
  • When does Mesoblast Limited report earnings?
  • Should I buy Mesoblast Limited stock now?

What is the ticker symbol for Mesoblast Limited?

The ticker symbol for Mesoblast Limited is NASDAQ:MESO

Does Mesoblast Limited pay dividends?

No, Mesoblast Limited does not pay dividends

What sector is Mesoblast Limited in?

Mesoblast Limited is in the Healthcare sector

What industry is Mesoblast Limited in?

Mesoblast Limited is in the Biotechnology industry

What country is Mesoblast Limited based in?

Mesoblast Limited is headquartered in Australia

When did Mesoblast Limited go public?

Mesoblast Limited's initial public offering (IPO) was on January 20, 2010

Is Mesoblast Limited in the S&P 500?

No, Mesoblast Limited is not included in the S&P 500 index

Is Mesoblast Limited in the NASDAQ 100?

No, Mesoblast Limited is not included in the NASDAQ 100 index

Is Mesoblast Limited in the Dow Jones?

No, Mesoblast Limited is not included in the Dow Jones index

When was Mesoblast Limited's last earnings report?

Mesoblast Limited's most recent earnings report was on Aug 28, 2024

When does Mesoblast Limited report earnings?

The next expected earnings date for Mesoblast Limited is Feb 28, 2025

Should I buy Mesoblast Limited stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions